Quantitative Assessment of Myeloid Nuclear Differentiation Antigen Distinguishes Myelodysplastic Syndrome From Normal Bone MarrowSara A. McClintock-Treep, David R. Head, Claudio A. Mosse et al.|American Journal of Clinical Pathology|2011Cited by 12
Innovative Analyses Support a Role for DNA Damage and an Aberrant Cell Cycle in Myelodysplastic Syndrome PathogenesisDavid R. Head, Keith Shults, James W. Jacobberger et al.|Bone Marrow Research|2011Cited by 10